Business
Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
Inhibition of FAK by AMP945 in Phase 1 Clinical Trial
About this update from Amplia Therapeutics Ltd.
[{"type":"text","content":"Amplia Therapeutics Ltd has released a press release. View Attachment","length":244,"tagName":"div"}]